Scarica l'app Stockscreener
1.21
2.42%
-0.03
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché JAGX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.24
Aprire:
$1.22
Volume 24 ore:
58,144
Relative Volume:
0.41
Capitalizzazione di mercato:
$4.52M
Reddito:
$10.48M
Utile/perdita netta:
$-37.74M
Rapporto P/E:
-0.0748
EPS:
-16.1846
Flusso di cassa netto:
$-29.03M
1 W Prestazione:
-32.02%
1M Prestazione:
-39.20%
6M Prestazione:
-71.60%
1 anno Prestazione:
-95.08%
Intervallo 1D:
$1.13
$1.3075
Intervallo di 1 settimana:
$1.13
$1.98
Portata 52W:
$1.13
$33.25
Jaguar Health Inc Stock (JAGX) Company Profile
Nome
Jaguar Health Inc
Settore
Industria
Telefono
415-371-8300
Indirizzo
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Confronta JAGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.21 | 4.63M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-07-11 | Iniziato | Rodman & Renshaw | Buy |
Jaguar Health Inc Borsa (JAGX) Ultime notizie
In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Clinical Trial - Wicked Local
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Lubbock Avalanche-Journal
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Times Herald-Record
Jaguar Health Amends Royalty Interests and Note Terms - MSN
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - The Tuscaloosa News
Jaguar Health (JAGX) Seeks Expedited FDA Approval for Crofelemer - GuruFocus
JAGXJaguar Health Inc Latest Stock News & Market Updates - Stock Titan
Is Jaguar Health Inc. (1JA0) stock a top hedge fund pickRate Cut & Fast Entry Momentum Alerts - newser.com
Can Jaguar Health Inc. (1JA0) stock stage a strong rebound this quarter2025 EndofYear Setup & Trade Opportunity Analysis - newser.com
Jaguar Health Inc. stock trendline breakdown2025 Sector Review & Stock Portfolio Risk Control - newser.com
What high frequency data says about Jaguar Health Inc.2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Will Jaguar Health Inc. (1JA0) stock beat international competitionTrade Exit Report & Weekly High Conviction Trade Ideas - newser.com
Has Jaguar Health Inc. formed a bullish divergenceWeekly Stock Summary & Weekly Market Pulse Alerts - newser.com
Will Jaguar Health Inc. (1JA0) stock profit from fiscal stimulusJuly 2025 Summary & Safe Capital Preservation Plans - newser.com
Can Jaguar Health Inc. stock surprise with earnings upsideJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Is Jaguar Health Inc. (1JA0) stock a buy before new product rollout2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Short interest data insights for Jaguar Health Inc.July 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
What earnings margins imply for Jaguar Health Inc. (1JA0) stock - newser.com
Live market analysis of Jaguar Health Inc.Analyst Downgrade & Safe Capital Preservation Plans - newser.com
Jaguar Health Reports Q3 2025 Financial Results - TipRanks
Jaguar Health Inc Azioni (JAGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):